On September 5, 2019 ESSA Pharma Inc. (TSX-V: EPI;Nasdaq: EPIX) ("ESSA" or the "Company"), a pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer reported the Company will be presenting at the H.C. Wainwright 21st Annual Global Investment Conference on Monday September 9, 2019 at 5:05pm EDT at the Lotte New York Palace Hotel in New York (Press release, ESSA, SEP 5, 2019, https://www.prnewswire.com/news-releases/essa-pharma-to-present-at-hc-wainwright-21st-annual-global-investment-conference-300912093.html [SID1234539328]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Dr. David. R. Parkinson, Chief Executive Officer, will provide a corporate overview of the Company’s business and will be available for one-on-one meetings from September 9 – 10, 2019. ESSA’s Chief Financial Officer, David S. Wood, and Chief Operating Officer, Peter Virsik, will also be in attendance.

The presentation will be webcast live and can be accessed through the Investor Relations page at www.essapharma.com. A replay of the presentation will be available on the Company’s website for 90 days.

Presentation Details :

Presentation Date:

Monday September 9, 2019

Presentation Time:

5:05pm Eastern Standard Time

Location:

Lotte New York Palace Hotel